PMLiVEcom Profile Banner
Pharmaceutical Market Europe Profile
Pharmaceutical Market Europe

@PMLiVEcom

Followers
16K
Following
358
Media
634
Statuses
21K

News & analysis of healthcare, pharma and biotech. Magazines, directories, profiles, jobs & awards.

Surrey, UK
Joined June 2009
Don't wanna be here? Send us removal request.
@PMLiVEcom
Pharmaceutical Market Europe
20 hours
Abivax shares positive late-stage results for obefazimod in ulcerative colitis
Tweet card summary image
pmlive.com
Inflammatory bowel disease affects nearly one in every 100 people in the US
0
1
1
@PMLiVEcom
Pharmaceutical Market Europe
20 hours
LEO’s Anzupgo granted FDA approval to treat moderate-to-severe chronic hand eczema
Tweet card summary image
pmlive.com
The cream is now the first treatment approved by the regulator specifically for this patient population
0
0
0
@PMLiVEcom
Pharmaceutical Market Europe
21 hours
Johnson & Johnson’s Darzalex approved by EC as first treatment for high-risk SMM
Tweet card summary image
pmlive.com
The early precursor of active multiple myeloma accounts for around 15% of all new multiple myeloma cases
0
0
0
@PMLiVEcom
Pharmaceutical Market Europe
1 day
Honoring the Legacy of Dr. Robert Sidbury, MD, MPH
Tweet card summary image
pmlive.com
We are deeply saddened by the recent passing of Dr. Robert Sidbury.
0
0
0
@PMLiVEcom
Pharmaceutical Market Europe
2 days
NICE recommends ALK’s immunotherapy to target underlying cause of hay fever
Tweet card summary image
pmlive.com
An estimated 26,800 people in England with moderate-to-severe cases could benefit from Itulazax
0
0
0
@PMLiVEcom
Pharmaceutical Market Europe
2 days
Roche’s Itovebi granted EC approval to treat advanced breast cancer patients
Tweet card summary image
pmlive.com
Hormone receptor-positive breast cancer accounts for around 70% of all breast cancer cases
0
0
0
@PMLiVEcom
Pharmaceutical Market Europe
2 days
AstraZeneca unveils plans to boost US footprint with $50bn investment
Tweet card summary image
pmlive.com
The funds will go towards establishing a multi-billion dollar drug substance facility in Virginia
0
0
0
@PMLiVEcom
Pharmaceutical Market Europe
3 days
Eli Lilly/Almirall’s Ebglyss shows promise in atopic dermatitis patients with darker skin tones
Tweet card summary image
pmlive.com
The inflammatory skin condition occurs in approximately 7.3% of adults in the US
0
0
0
@PMLiVEcom
Pharmaceutical Market Europe
3 days
Biogen to boost US manufacturing footprint with $2bn North Carolina investment
Tweet card summary image
pmlive.com
The commitment is aimed at advancing the company's late-stage clinical pipeline
0
0
0
@PMLiVEcom
Pharmaceutical Market Europe
3 days
Sanofi to expand respiratory vaccines pipeline with $1.6bn Vicebio acquisition
Tweet card summary image
pmlive.com
The deal includes an early-stage combination vaccine candidate for RSV and hMPV
0
0
0
@PMLiVEcom
Pharmaceutical Market Europe
3 days
In the latest issue of PME, Karen Harris explores how current market challenges are redefining the biotech landscape. Check out her article below: #Biotech #DrugFunding #Pharma #Health #PME.
Tweet card summary image
pmlive.com
Short-term uncertainty is slowing investment activity, but the long-term outlook remains strong
0
0
0
@PMLiVEcom
Pharmaceutical Market Europe
3 days
US Payer Panel Insights Survey: Evolving Evidence Landscape and Priorities
Tweet card summary image
pmlive.com
Download the first edition of the Petauri ‘US Payer Panel Insights Survey: Evolving Evidence Landscape and Priorities’ report
0
0
0
@PMLiVEcom
Pharmaceutical Market Europe
4 days
EC approves SpringWorks Therapeutics’ Ezmekly to treat rare genetic disorder NF1
pmlive.com
Neurofibromatosis type 1 affects an estimated 135,000 people in the EU
0
1
0